.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Baxter
Cerilliant
Chinese Patent Office
Deloitte
UBS
US Army
Julphar
US Department of Justice

Generated: September 22, 2017

DrugPatentWatch Database Preview

SOMA COMPOUND W/ CODEINE Drug Profile

« Back to Dashboard

Which patents cover Soma Compound W/ Codeine, and when can generic versions of Soma Compound W/ Codeine launch?

Soma Compound W/ Codeine is a drug marketed by Meda Pharms and is included in one NDA.

The generic ingredient in SOMA COMPOUND W/ CODEINE is aspirin; carisoprodol; codeine phosphate. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.

Summary for Tradename: SOMA COMPOUND W/ CODEINE

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list1,268
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SOMA COMPOUND W/ CODEINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meda Pharms
SOMA COMPOUND W/ CODEINE
aspirin; carisoprodol; codeine phosphate
TABLET;ORAL012366-002Jul 11, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SOMA COMPOUND W/ CODEINE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Meda Pharms
SOMA COMPOUND W/ CODEINE
aspirin; carisoprodol; codeine phosphate
TABLET;ORAL012366-002Jul 11, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
US Department of Justice
Accenture
McKesson
Mallinckrodt
Cerilliant
Fish and Richardson
QuintilesIMS
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot